CDC Determines Prevalence of Osteoporosis in Older Adults

Share this content:
CDC Determines Prevalence of Osteoporosis in Older Adults
CDC Determines Prevalence of Osteoporosis in Older Adults

THURSDAY, Aug. 13, 2015 (HealthDay News) -- The prevalence of osteoporosis and low bone density has been examined among adults aged 65 years and older. The findings were published online Aug. 13 by the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics (NCHS).

Anne C. Looker, Ph.D., and Steven M. Frenk, Ph.D., from the NCHS, used data from the 2005 to 2010 National Health and Nutrition Examination Surveys to examine the prevalence of osteoporosis and low bone mass at the femur neck or lumbar spine among U.S. adults aged 65 years and older.

The researchers found that 16.2 percent of adults had osteoporosis, with age-adjusted prevalence being 24.8 and 5.6 percent among women and men, respectively. The unadjusted prevalence was 25.7 and 12.8 percent among those aged 80 years and older and those aged 65 to 79 years, respectively. The unadjusted prevalence of osteoporosis was 24.9, 15.7, and 10.3 percent among Mexican-Americans, non-Hispanic whites, and non-Hispanic blacks, respectively. Low bone mass was seen in 48.3 percent of adults aged 65 years or older, with higher prevalence seen among women versus men (52.3 versus 44.0 percent). Prevalence was higher in adults aged 80 years or older versus those aged 65 to 79 years (52.7 versus 46.7 percent).

"Recent estimates of the prevalence of osteoporosis and low bone mass at the femur neck or lumbar spine in U.S. adults focused on adults aged 50 and over," the authors write. "There is also interest in the prevalence of osteoporosis among adults aged 65 and over because most adults in this group are eligible for Medicare coverage."

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »